Joline S.J. Lim

2.1k total citations
56 papers, 805 citations indexed

About

Joline S.J. Lim is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Joline S.J. Lim has authored 56 papers receiving a total of 805 indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Oncology, 20 papers in Pulmonary and Respiratory Medicine and 16 papers in Cancer Research. Recurrent topics in Joline S.J. Lim's work include Cancer Treatment and Pharmacology (14 papers), HER2/EGFR in Cancer Research (12 papers) and Advanced Breast Cancer Therapies (12 papers). Joline S.J. Lim is often cited by papers focused on Cancer Treatment and Pharmacology (14 papers), HER2/EGFR in Cancer Research (12 papers) and Advanced Breast Cancer Therapies (12 papers). Joline S.J. Lim collaborates with scholars based in Singapore, United Kingdom and United States. Joline S.J. Lim's co-authors include Raghav Sundar, David S.P. Tan, Timothy A. Yap, Dearbhaile Catherine Collins, Ross A. Soo, Soo Chin Lee, John M. Luk, Sheung Tat Fan, Manuel Salto‐Tellez and Henry Yang and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Joline S.J. Lim

52 papers receiving 791 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joline S.J. Lim Singapore 14 392 303 162 144 129 56 805
Simon J. Hollingsworth United Kingdom 16 351 0.9× 350 1.2× 224 1.4× 153 1.1× 61 0.5× 56 951
Lucrezia Silvestro Italy 14 603 1.5× 125 0.4× 256 1.6× 139 1.0× 151 1.2× 29 835
Sara López‐Tarruella Spain 19 672 1.7× 228 0.8× 277 1.7× 240 1.7× 90 0.7× 89 962
Adam Garsa United States 16 345 0.9× 117 0.4× 96 0.6× 167 1.2× 99 0.8× 40 749
Theodore A. Vandenberg Canada 12 463 1.2× 206 0.7× 161 1.0× 110 0.8× 97 0.8× 26 774
Rubina Qamar United States 12 479 1.2× 203 0.7× 210 1.3× 239 1.7× 83 0.6× 21 908
Zhaozhi Yang China 18 326 0.8× 209 0.7× 397 2.5× 273 1.9× 151 1.2× 57 986
Yunjiang Liu China 13 517 1.3× 186 0.6× 188 1.2× 235 1.6× 154 1.2× 57 813
Alfonso Sánchez‐Muñoz Spain 19 537 1.4× 234 0.8× 361 2.2× 186 1.3× 91 0.7× 56 1.0k
Joo Han Lim South Korea 18 393 1.0× 335 1.1× 163 1.0× 144 1.0× 30 0.2× 61 867

Countries citing papers authored by Joline S.J. Lim

Since Specialization
Citations

This map shows the geographic impact of Joline S.J. Lim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joline S.J. Lim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joline S.J. Lim more than expected).

Fields of papers citing papers by Joline S.J. Lim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joline S.J. Lim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joline S.J. Lim. The network helps show where Joline S.J. Lim may publish in the future.

Co-authorship network of co-authors of Joline S.J. Lim

This figure shows the co-authorship network connecting the top 25 collaborators of Joline S.J. Lim. A scholar is included among the top collaborators of Joline S.J. Lim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joline S.J. Lim. Joline S.J. Lim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Walsh, Robert J., Matilda Lee, Natalie Y.L. Ngoi, et al.. (2024). Molecular profiling of metastatic breast cancer and target-based therapeutic matching in an Asian tertiary phase I oncology unit. Frontiers in Oncology. 14. 1342346–1342346.
3.
Aftimos, Philippe, Nicholas C. Turner, Joyce O’Shaughnessy, et al.. (2023). 386MO Trastuzumab duocarmazine versus physician's choice therapy in pre-treated HER2-positive metastatic breast cancer: Final results of the phase III TULIP trial. Annals of Oncology. 34. S340–S341. 16 indexed citations
4.
Zhao, Joseph J., Khi Yung Fong, Yiong Huak Chan, et al.. (2023). Indirect Treatment Comparison of First-Line CDK4/6-Inhibitors in Post-Menopausal Patients with HR+/HER2− Metastatic Breast Cancer. Cancers. 15(18). 4558–4558. 5 indexed citations
5.
Yong, Wei Peng, Raghav Sundar, Soo Chin Lee, et al.. (2023). Clinical outcome and prognostic factors for Asian patients in Phase I clinical trials. British Journal of Cancer. 128(8). 1514–1520. 2 indexed citations
6.
Lim, Joline S.J., Ryan Tan, Ainsley Ryan Yan Bin Lee, et al.. (2023). COVID-19 Severity and Waning Immunity After up to 4 mRNA Vaccine Doses in 73 608 Patients With Cancer and 621 475 Matched Controls in Singapore. JAMA Oncology. 9(9). 1221–1221. 11 indexed citations
7.
8.
Wong, Andrea L.A., Samuel G.W. Ow, Raghav Sundar, et al.. (2022). Phase Ib Dose-Finding Study of Varlitinib Combined with Weekly Paclitaxel With or Without Carboplatin ± Trastuzumab in Advanced Solid Tumors. Targeted Oncology. 17(2). 141–151. 5 indexed citations
9.
Lim, Joline S.J., Raghav Sundar, Andrew Barnabas Wong, et al.. (2021). 515MO A phase I trial of durvalumab (Durv) in combination with olaparib (Ola) and capivasertib (Cap) in patients (pts) with advanced or metastatic cancers (Ca) (MEDIPAC). Annals of Oncology. 32. S585–S586. 1 indexed citations
10.
Lim, Joline S.J., Joan Choo, Samuel G.W. Ow, et al.. (2021). Immunohistochemistry study of tumor vascular normalization and anti-angiogenic effects of sunitinib versus bevacizumab prior to dose-dense doxorubicin/cyclophosphamide chemotherapy in HER2-negative breast cancer. Breast Cancer Research and Treatment. 192(1). 131–142. 13 indexed citations
11.
Ang, Yvonne, Gwo Fuang Ho, Ross A. Soo, et al.. (2020). A randomized phase II trial evaluating the addition of low dose, short course sunitinib to docetaxel in advanced solid tumours. BMC Cancer. 20(1). 1118–1118. 5 indexed citations
12.
Bandla, Aishwarya, Nesaretnam Barr Kumarakulasinghe, Yiqing Huang, et al.. (2019). Safety and tolerability of cryocompression as a method of enhanced limb hypothermia to reduce taxane-induced peripheral neuropathy. Supportive Care in Cancer. 28(8). 3691–3699. 22 indexed citations
13.
Sundar, Raghav, Terri McVeigh, David Dolling, et al.. (2018). Clinical outcomes of adolescents and young adults with advanced solid tumours participating in phase I trials. European Journal of Cancer. 101. 55–61. 6 indexed citations
14.
Sundar, Raghav, Ana Custodio, Maxime Chénard-Poirier, et al.. (2017). Clinical Outcome of Patients with Advanced Biliary Tract Cancer in a Dedicated Phase I Unit. Clinical Oncology. 30(3). 185–191. 3 indexed citations
15.
Lim, Joline S.J., et al.. (2017). Breast reconstruction rate and profile in a Singapore patient population: a National University Hospital experience. Singapore Medical Journal. 59(6). 300–304. 10 indexed citations
16.
Soo, Ross A., Yvonne Ang, & Joline S.J. Lim. (2016). Profile of nivolumab in the treatment of metastatic squamous non-small-cell lung cancer. OncoTargets and Therapy. 9. 3187–3187. 12 indexed citations
17.
Sia, Ching‐Hui, Joline S.J. Lim, Kian Keong Poh, & Tan Min Chin. (2016). A classical case of non-bacterial thrombotic endocarditis from pancreatic adenocarcinoma presenting as multiple strokes, myocardial infarction and acute limb ischaemia. Oxford Medical Case Reports. 2016(11). omw084–omw084. 6 indexed citations
18.
Collins, Dearbhaile Catherine, Raghav Sundar, Joline S.J. Lim, & Timothy A. Yap. (2016). Towards Precision Medicine in the Clinic: From Biomarker Discovery to Novel Therapeutics. Trends in Pharmacological Sciences. 38(1). 25–40. 80 indexed citations
19.
Yong, Kol Jia, Chong Gao, Joline S.J. Lim, et al.. (2013). Oncofetal Gene SALL4 in Aggressive Hepatocellular Carcinoma. New England Journal of Medicine. 368(24). 2266–2276. 198 indexed citations
20.
Yeo, Leonard L.L., Joline S.J. Lim, & Vijay K. Sharma. (2009). Spinal epidural hematoma after intravenous thrombolysis for acute ischemic stroke. Journal of the Neurological Sciences. 284(1-2). 190–191. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Simon J. Hollingsworth Breakdown of academic impact, for papers by Lucrezia Silvestro Breakdown of academic impact, for papers by Sara López‐Tarruella Breakdown of academic impact, for papers by Adam Garsa Breakdown of academic impact, for papers by Theodore A. Vandenberg Breakdown of academic impact, for papers by Rubina Qamar Breakdown of academic impact, for papers by Zhaozhi Yang Breakdown of academic impact, for papers by Yunjiang Liu Breakdown of academic impact, for papers by Alfonso Sánchez‐Muñoz Breakdown of academic impact, for papers by Joo Han Lim
Rankless by CCL
2026